List of Tables
Table 1 Global Cancer Incidence, 2018 vs 2025
Table 2 Cell Surface Markers Market, By Product, 2016-2023 (USD Million)
Table 3 Cell Surface Marker Antibodies Market, By Region, 2016-2023 (USD Million)
Table 4 Cell Surface Marker Pcr Arrays Market, By Region, 2016-2023 (USD Million)
Table 5 Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 6 Cell Surface Marker Antibodies Market for Mice, By Region, 2016-2023 (USD Million)
Table 7 Cell Surface Marker Antibodies Market for Rats, By Region, 2016-2023 (USD Million)
Table 8 Cell Surface Marker Antibodies Market for Other Sources, By Region, 2016-2023 (USD Million)
Table 9 Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 10 T Cell Surface Markers Market, By Region, 2016-2023 (USD Million)
Table 11 B Cell Surface Markers Market, By Region, 2016-2023 (USD Million)
Table 12 NK Cell Surface Markers Market, By Region, 2016-2023 (USD Million)
Table 13 Monocyte Cell Surface Markers Market, By Region, 2016-2023 (USD Million)
Table 14 Markers Market for Other Cell Types, By Region, 2016-2023 (USD Million)
Table 15 Markers Market, By Application, 2016-2023 (USD Million)
Table 16 Markers Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 17 Markers Market for Research Applications, By Region, 2016-2023 (USD Million)
Table 18 Markers Market for Drug Discovery, By Region, 2016-2023 (USD Million)
Table 19 Markers Market for Immunology, By Region, 2016-2023 (USD Million)
Table 20 Markers Market for Stem Cell Research, By Region, 2016-2023 (USD Million)
Table 21 Markers Market for Other Research Applications, By Region, 2016-2023 (USD Million)
Table 22 Markers Market for Clinical Applications, By Type, 2016-2023 (USD Million)
Table 23 Markers Market for Clinical Applications, By Region, 2016-2023 (USD Million)
Table 24 Markers Market for Oncology, By Region, 2016-2023 (USD Million)
Table 25 Markers Market for Immunodeficiency Diseases, By Region, 2016-2023 (USD Million)
Table 26 Markers Market for Other Clinical Applications, By Region, 2016-2023 (USD Million)
Table 27 Markers Market, By End User, 2016-2023 (USD Million)
Table 28 Markers Market for Academic & Research Institutes, By Region, 2016-2023 (USD Million)
Table 29 Markers Market for Hospitals & Clinical Testing Laboratories, By Region, 2016-2023 (USD Million)
Table 30 Markers Market for Pharmaceutical & Biotechnology Companies, By Region, 2016-2023 (USD Million)
Table 31 Cell Surface Markers Market, By Region, 2016-2023 (USD Million)
Table 32 North America: Cell Surface Markers Market, By Country, 2016-2023 (USD Million)
Table 33 North America: Market, By Product, 2016-2023 (USD Million)
Table 34 North America: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 35 North America: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 36 North America: Market, By Application, 2016-2023 (USD Million)
Table 37 North America: Cell Surface Markers Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 38 North America: Cell Surface Markers Market for Clinical Applications, By Type, 2016-2023 (USD Million)
Table 39 North America: Market, By End User, 2016-2023 (USD Million)
Table 40 US: Cell Surface Markers Market, By Product, 2016-2023 (USD Million)
Table 41 US: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 42 US: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 43 US: Market, By Application, 2016-2023 (USD Million)
Table 44 US: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 45 Canada: Market, By Product, 2016-2023 (USD Million)
Table 46 Canada: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 47 Canada: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 48 Canada: Market, By Application, 2016-2023 (USD Million)
Table 49 Canada: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 50 Europe: Market, By Country, 2016-2023 (USD Million)
Table 51 Europe: Cell Surface Markers Market, By Product, 2016-2023 (USD Million)
Table 52 Europe: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 53 Europe: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 54 Europe: Market, By Application, 2016-2023 (USD Million)
Table 55 Europe: Cell Surface Markers Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 56 Europe: Market for Clinical Applications, By Type, 2016-2023 (USD Million)
Table 57 Europe: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 58 Germany: Market, By Product, 2016-2023 (USD Million)
Table 59 Germany: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 60 Germany: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 61 Germany: Market, By Application, 2016-2023 (USD Million)
Table 62 Germany: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 63 France: Market, By Product, 2016-2023 (USD Million)
Table 64 France: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 65 France: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 66 France: Market, By Application, 2016-2023 (USD Million)
Table 67 France: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 68 UK: Market, By Product, 2016-2023 (USD Million)
Table 69 UK: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 70 UK: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 71 UK: Market, By Application, 2016-2023 (USD Million)
Table 72 UK: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 73 RoE: Market, By Product, 2016-2023 (USD Million)
Table 74 RoE: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 75 RoE: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 76 RoE: Market, By Application, 2016-2023 (USD Million)
Table 77 RoE: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 78 Asia: Cell Surface Markers Market, By Product, 2016-2023 (USD Million)
Table 79 Asia: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 80 Asia: Market, By Cell Type, 2016-2023 (USD Million)
Table 81 Asia: Cell Surface Markers Market, By Application, 2016-2023 (USD Million)
Table 82 Asia: Cell Surface Markers Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 83 Asia: Market for Clinical Applications, By Type, 2016-2023 (USD Million)
Table 84 Asia: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
Table 85 RoW: Market, By Product, 2016-2023 (USD Million)
Table 86 RoW: Cell Surface Marker Antibodies Market, By Source, 2016-2023 (USD Million)
Table 87 RoW: Cell Surface Markers Market, By Cell Type, 2016-2023 (USD Million)
Table 88 RoW: Market, By Application, 2016-2023 (USD Million)
Table 89 RoW: Cell Surface Markers Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 90 RoW: Market for Clinical Applications, By Type, 2016-2023 (USD Million)
Table 91 RoW: Cell Surface Markers Market, By End User, 2016-2023 (USD Million)
List of Figures
Figure 1 Cell Surface Marker Market Segmentation
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Cell Surface Markers Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 Cell Surface Marker Antibodies Market, By Source
Figure 8 Cell Surface Markers Market, By Cell Type, 2018 vs 2023 (USD Million)
Figure 9 Cell Surface Markers Market, By Application, 2018 vs 2023 (USD Million)
Figure 10 Cell Surface Markers Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Cell Surface Markers Market
Figure 12 High Global Burden of Cancer & Increasing Funding for Life Science Research are Driving the Growth of the Cell Surface Markers Market
Figure 13 Antibodies Segment to Register the Highest Growth During the Forecast Period
Figure 14 T Cell Surface Markers Segment to Account for the Largest Market Share in 2018
Figure 15 Clinical Applications Segment to Witness the Highest Growth During the Forecast Period
Figure 16 Academic & Research Institutes Segment to Dominate the Cell Surface Markers Market During the Forecast Period
Figure 17 Asia is the Fastest-Growing Region in the Cell Surface Markers Market
Figure 18 Cell Surface Markers Market: Drivers, Restraints, and Opportunities
Figure 19 Antibodies Segment Will Continue to Dominate the Cell Surface Marker Products Market During the Forecast Period
Figure 20 Mice Segment to Witness the Highest Growth in the Cell Surface Marker Antibodies Market During the Forecast Period
Figure 21 T Cell Surface Markers Segment to Dominate the Market During the Forecast Period
Figure 22 Research Applications Segment to Account for the Largest Share of the Cell Surface Markers Market in 2018
Figure 23 Hospitals & Clinical Testing Laboratories Segment to Witness the Highest Growth During the Forecast Period
Figure 24 North America: Cell Surface Markers Market Snapshot
Figure 25 Europe: Cell Surface Markers Market Snapshot
Figure 26 Asia: Cell Surface Markers Market Snapshot
Figure 27 RoW: Cell Surface Markers Market Snapshot
Figure 28 Key Developments in the Cell Surface Markers Market (Jan 2016-Nov 2018)
Figure 29 Market Evolution Framework
Figure 30 Cell Surface Markers Market Ranking Analysis, By Key Player (2017)
Figure 31 Company Snapshot: Thermo Fisher Scientific (2017)
Figure 32 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 33 Company Snapshot: Abcam (2018*)
Figure 34 Company Snapshot: Qiagen N.V. (2017)
Figure 35 Company Snapshot: F. Hoffmann-La Roche AG (2017)
Figure 36 Company Snapshot: Bio-Rad Laboratories, Inc. (2017)
Figure 37 Company Snapshot: Danaher Corporation (2017)
Figure 38 Company Snapshot: Genscript (2017)
Figure 39 Company Snapshot: Bio-Techne (2017)
Figure 40 Company Snapshot: Merck KGaA (2017)